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Sarcopenia · Bone mineral density · Older adults
Abstract
Objective: To verify the association between sarcopenia and 
osteopenia/osteoporosis in the older population from Flori-
anópolis, Southern Brazil. Methods: A cross-sectional study 
with 598 older adults. The bone mineral density (BMD) was 
evaluated by total BMD, lumbar spine BMD (LS-BMD), femo-
ral neck BMD (FN-BMD), and osteopenia/osteoporosis was 
defined when BMD (g/cm2) <–1 standard deviation of the 
sample mean. Sarcopenia was identified by the appendicu-
lar muscle mass index (AMMI), by sex, when AMMI < 7.26 kg/
m2 for men and < 5.5 kg/m2 for women. Results: Of the 598 
subjects (63–93 years) in the sample, 65.4% were women. 
The proportion of altered BMD was 52.1% for total BMD, 
62.5% for LS-BMD, and 70.9% for FN-BMD in women, while 
for men, altered BMD proportion was 29.3% for total BMD, 
24.5% for LS-BMD, and 64.9% for FN-BMD. After adjustments, 
sarcopenia was associated with increased odds of altered LS-
BMD (OR: 12.25; 95% CI: 3.66–40.96 and OR: 2.90; 95% CI: 
1.30–6.48) and FN-BMD (OR: 5.59; 95% CI: 1.64–19.05 and OR: 
7.95; 95% CI: 3.23–19.57), respectively for women and men. 
The association between sarcopenia and altered total BMD 
(OR: 11.08; 95% CI: 3.84–31.97) was observed only in women. 
Conclusion: The proportion of osteopenia/osteoporosis was 
higher in women. Sarcopenia was associated with osteope-
nia/osteoporosis in the population from Florianópolis, ex-
cept for total BMD in men.
© 2020 The Author(s). Published by S. Karger AG, Basel
on behalf of NOVA National School of Public Health
Osteopenia/osteoporose e sua associação com 
sarcopenia: Estudo EpiFloripa Idoso 2013/2014
Palavras Chave
Sarcopenia · Densidade mineral óssea · Idoso
Resumo
Objetivo: Verificar a associação entre sarcopenia e osteo-
penia/osteoporose em idosos de Florianópolis, Sul do 
Brasil. Métodos: Trata-se de estudo transversal com 598 
idosos. A osteopenia/osteoporose foi identificada por 
meio da densidade mineral óssea (DMO) total, DMO colu-
na lombar (DMO-CL) e DMO colo do fêmur (DMO-CF), sen-
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do considerada alterada quando DMO (g/cm2) <–1 desvio 
padrão da média da amostra. A sarcopenia foi identificada 
por meio do índice de massa muscular apendicular (IMMA, 
Kg/m2), de acordo com o sexo, quando IMMA < 7,26 kg/m2 
para homens e < 5,5 kg/m2 para mulheres. Resultados: 
Dos 598 indivíduos (63 a 93 anos) da amostra, 65,4% eram 
mulheres. A prevalência de osteopenia/osteoporose foi 
52,1% para DMO-total, 62,5% para DMO-CL e 70,9% para 
DMO-CF nas mulheres. Para os homens, a osteopenia/os-
teoporose foi de 29,3% para DMO total, 24,5% para DMO-
CL e 64,9% para DMO-CF. Após ajustes, a sarcopenia foi 
associada a maiores chances de DMO-CL alterada (OR: 
12,25; IC 95%: 3,66–40,96 e OR: 2,90; IC 95%: 1,30–6,48) e 
DMO-CF alterada (OR: 5,59; IC 95%: 1,64–19,05 e OR: 7,95; 
IC 95%: 3,23–19,57), para mulheres e homens, respectiva-
mente. A sarcopenia foi associada à DMO-total alterada 
(OR: 11,08; IC 95%: 3,84–31,97) apenas em mulheres. Con-
clusão: A prevalência de osteopenia/osteoporose foi 
maior entre as mulheres. Idosos sarcopênicos apresentam 
maiores chances de ter osteopenia/osteoporose, exceto 
para DMO total em homens.
© 2020 The Author(s). Published by S. Karger AG, Basel 
on behalf of NOVA National School of Public Health
Introduction
With the accelerated population aging and the tenden-
cy of involution of the bone and muscle tissues among 
older adults, the consequences of these muscular and 
bone changes are approaching the epidemic status [1].
Osteopenia is characterized by low bone mineral den-
sity (BMD) and has been found in 5–50% of older adults 
[2–5]. As the bone tissue deteriorates, osteopenia can lead 
to a skeletal disease known as osteoporosis. Also, with ad-
vancing age, a decrease in muscle mass and function, rec-
ognized as sarcopenia, reaches 5–13% of those with 60–70 
years of age and up to 50% among people over 80 years 
[2, 3, 6].
The literature has documented a few mechanisms on 
how sarcopenia and bone interact, through genetic, mo-
lecular [1, 7], mechanical [1, 6], and functional alterations 
[3, 6]. The complications of these conditions have a great 
socioeconomic impact on the population [8, 9]. The de-
cline of muscle and bone strength presents manifesta-
tions in the reduction of mobility and functionality, 
greater predisposition to falls, fractures [10, 11], func-
tional dependence, and increased morbidity and mortal-
ity risk [1, 12]. Older adults who present sarcopenia and 
osteoporosis generally require more health care and spe-
cialized long-term care, which represents high costs and 
considerable social impact [8, 9].
In Brazil, the few studies about sarcopenia and BMD 
at older ages are with outpatients [13], small samples [13–
16], 80 years or older [16], overweight [17], and with dif-
ferent definition criteria [18]. Only the accumulation of 
work assigns some degree of consistency to the findings; 
therefore, the objective of the present study was to verify 
the association between sarcopenia and osteopenia/os-
teoporosis in older residents from the city of Florianópo-
lis, Southern Brazil.
Methods
This study is part of the follow-up of the epidemiological re-
search entitled “Conditions of Health of the Elderly in Florianópo-
lis – EpiFloripa Aging Study,” whose baseline was carried out in 
2009/2010 and the follow-up in 2013/2014. The EpiFloripa Aging 
Study is a longitudinal, population- and household-based study 
with individuals aged 60 years or older living in the city of Flori-
anópolis, Southern Brazil. The details of the study such as popula-
tion and sampling were previously published, and so it will be pre-
sented briefly [19, 20]. It was a two-stage sampling strategy, the first 
stage was the urban census tracts of the city, stratified in ascending 
order of monthly average income of the head of the family, and the 
second stage was the households of these sectors. Both units were 
drawn systematically. If one of the households had two or more 
older adults, they would all be invited to participate in the study.
Data was collected through domiciliary (face to face) interviews 
with a structured questionnaire in netbooks to record the data. The 
consistency analysis of the data occurred weekly, and quality con-
trol was conducted by telephone through a reduced questionnaire 
application in 10% of the interviews (selected randomly). Partici-
pants from the follow-up (2013/2014) were invited to perform tests 
at the Health Sciences Center of the Federal University of Santa 
Catarina (UFSC).
The baseline sample consisted of 1,705 participants. To the fol-
low-up, 3 interviews were excluded (2 duplicates data and 1 in-
compatible age) and 217 deaths were identified. From the 1,485 
eligible participants, 159 were losses, 129 refused, and 1,197 
(80.6%) were interviewed in 2013/2014. From the 1,197 partici-
pants, 604 (50.4%) participated in the tests, such as body composi-
tion, bone densitometry, and biological exams (vitamin D). Due to 
inappropriate information in the image tests, the analytical sample 
consisted of 598 individuals.
Between the 2013/2014 sample (1,197 participants) and the 
tests (598 participants), there were losses for the age group (p < 
0.001), mostly 80 years or older, cognitive deficit (p < 0.001), and 
dependence on activities of daily living (ADL) (p = 0.003) (data not 
shown).
Dependent Variables
Osteopenia/osteoporosis was identified by BMD from total 
BMD, lumbar spine BMD (LS-BMD), and femoral neck BMD 
(FN-BMD). The evaluation of BMD (g/cm2) was done with the 
dual energy X-ray absorptiometry (DXA; model Lunar Prodigy 
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Table 1. Description of the sample according to demographic, socioeconomic, lifestyle, health conditions, sarco-
penia, and bone mineral density of older adults; Florianópolis, Southern Brazil, 2013/2014
Variables Women (n = 391),
mean age (SD) = 72.5 (6.2)
Men (n = 207),
mean age (SD) = 72.0 (6.4)
n % (95% CI) n % (95% CI)
Education level
No formal education 26 6.2 (3.7–10.2) 14 5.2 (2.7–9.8)
1–4 years 155 39.2 (31.4–47.5) 60 24.5 (2.49–31.7)
5–8 years 72 18.4 (14.0–23.6) 34 20.2 (13.6–29.0)
9–11 years 70 18.5 (14.1–23.9) 24 16.9 (11.8–23.6)
12 or more 67 17.7 (13.0–23.7) 75 33.1 (28.8–41.2)
Alcohol consumption
No 270 69.0 (62.5–74.8) 76 33.7 (25.9–42.5)
Moderate 97 24.4 (19.2–30.4) 64 29.2 (22.4–37.0)
High 24 6.6 (4.0–10.7) 67 37.1 (28.4–46.8)
Smoking habit
Never 300 74.7 (67.9–80.5) 75 31.0 (24.5–38.3)
Former and stopped 68 19.7 (14.8–25.6) 111 58.4 (51.3–62.3)
Current 23 5.6 (3.4–9.1) 21 10.6 (66.5–16.4)
Physical activity
Insufficiently active 192 48.5 (42.3–54.8) 64 27.3 (20.0–35.9)
Physically active 199 51.5 (45.2–57.7) 143 72.7 (64.0–79.9)
Dependency on activities of daily living
No 276 70.4 (62.5–77.3) 167 82.14 (22.7–37.5)
Yes 115 29.6 (22.7–37.5) 37 17.86 (11.4–26.9)
Falls (last year)
No 260 66.1 (61.2–70.7) 160 76.1 (68.6–82.3)
Yes 131 33.9 (29.3–38.8) 47 23.9 (17.7–31.4)
Sarcopenia
No 328 83.0 (77.1–87.6) 148 71.2 (62.3–78.6)
Yes 63 17.0 (12.4–22.9) 59 28.8 (21.3–37.7)
Total BMD
Normal 191 47.9 (40.3–55.5) 140 71.0 (61.7–77.3)
Altered 199 52.1 (44.5–59.6) 67 29.0 (22.7–36.3)
Lumbar spine BMD
Normal 150 37.5 (30.7–44.8) 147 75.48 (67.1–82.3)
Altered 240 62.5 (55.2–69.3) 60 24.52 (17.7–32.9)
Femoral neck BMD
Normal 108 29.1 (23.4–35.4) 69 35.0 (25.7–45.6)
Altered 282 70.9 (64.6–76.6) 138 64.9 (54.3–74.2)
Vitamin D
Normal 101 30.5 (23.6–38.5) 93 43.4 (36.2–50.8)
Hypovitaminosis 271 69.5 (61.5–76.4) 106 56.6 (49.2–63.8)
Seasons
Spring 55 15.7 (10.7–22.4) 29 18.0 (11.6–26.7)
Summer 44 9.4 (6.2–14.1) 19 9.5 (5.4–16.1)
Autumn 178 52.6 (42.9–62.1) 97 46.5 (36.6–56.8)
Winter 95 22.3 (16.1–30.0) 54 26.0 (19.0–34.5)
SD, standard deviation; BMD, bone mineral density; 95% CI, 95% confidence interval.
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Advance by General Electric). The mean values of each BMD from 
the sample of this study were calculated and according to the con-
sensus of the World Health Organization [21] considered as nor-
mal when up to –1 standard deviation (SD) of the mean. Osteope-
nia/osteoporosis was defined by BMD <–1 SD of the sample mean 
(osteopenia: –1 to –2.5 SD, and osteoporosis: <–2.5 SD) [14].
All participants received information on the purpose of the test 
before the evaluation and were asked to remove metal objects. Par-
ticipants also received instructions to remain immobile and silent 
during the procedure, which was repeated if necessary. The ex-
amination was carried out according to DXA manual, and it lasted 
an average of 15 min for the total body scan, lumbar spine densi-
tometry, and femoral neck densitometry.
Independent Variable
Sarcopenia was identified through muscle mass analysis from 
DXA. The criteria was appendicular skeletal muscle index (ASMI) 
≤2 SD, according to a reference population mean of young adults 
in the Rosetta study, by sex [22]. The cut-off points for inadequate 
ASMI (kg/m2) (sarcopenia) were < 7.26 kg/m2 for men and < 5.5 
kg/m2 for women, considering sarcopenia (no/yes). We used the 
ASMI formula proposed by Baumgartner et al. [22]: ASMI (kg/m2) 
= lean muscle mass of the arms (kg) + lean muscle mass of the legs 
(kg)/height2 (m).
Variables Adjustment
The adjustment variables, based on the literature [23, 24], were: 
age (continuous), education level in years (no formal education, 1–4, 
5–8, 9–11, and 12 or more years), smoking habit (never smoked, for-
mer smoker and stopped, current smoker), consumption of alco-
holic beverage, leisure and transportation physical activity, falls in the 
last year, dependency on ADL, and vitamin D (25 hydroxy).
To verify the consumption of alcoholic beverages (does not 
consume, non-abusive consumption, and abusive consumption), 
we used the first three questions of the questionnaire The Alcohol 
Use Disorders Identification Test (AUDIT) [25]. The leisure and 
transportation physical activity evaluation was measured by the 
long version of the International Physical Activity Questionnaire 
(IPAQ) [26] (insufficiently active [< 150 min weekly of leisure and 
transportation physical activity] and physically active [≥150 min 
weekly of leisure and transportation physical activity]). The inves-
tigation of falls in the last year was through the question: “Have 
you suffered any fall in the last year?” categorized as yes or no. To 
evaluate the dependency on ADL [27] the Brazilian Questionnaire 
of Multidimensional Functional Evaluation was used, adapted 
from the questionnaire Old Americans Resources and Services 
(BOMFAQ/OARS): no (no dependence or dependence on up to 3 
activities) and yes (dependence on 4 or more activities).
For the evaluation of vitamin D (25 hydroxy), blood samples 
were collected after fasting of 8 h. The serum samples were imme-
diately frozen, and the vitamin D analyzed between November 
2016 and April 2017 by microparticle chemiluminescence method 
(CMIA)/Liaison. The vitamin levels were classified according to 
the Brazilian Society of Endocrinology and Metabolism (Socie-
dade Brasileira de Endocrinologia e Metabologia – SBEM) [28] 
recommendations, as normal (30–100 mg/mL) and hypovitamin-
osis (< 30 mg/mL). As vitamin D status is partially dependent on 
exposure to sunlight, which results in higher serum 25-OHD levels 
in spring/summer, compared to the fall/winter season, we used the 
season when the blood test was taken in the adjusted analysis.
Data Analysis
Descriptive analyses (proportion) were performed for all vari-
ables, and logistic regression was used to estimate the crude and 
adjusted odds ratios with their respective 95% confidence interval 
(CI). We considered three adjustments models in the association 
for sarcopenia and each BMD variable: model 1 adjusted by age 
and schooling; model 2 adjusted for age, schooling, smoking, alco-
hol consumption, physical activity, falls and functional depen-
dence; model 3 adjusted for age, schooling, smoking, alcohol con-
sumption, physical activity, falls, functional dependence, vitamin 
D, and season. The level of statistical significance was 5%.
Data was analyzed on the statistical program Stata 13.0 (Stata 
Corp., College Station, EUA). We considered the effect of the sam-
ple design by conglomerates and the sample weight with the com-
mand svy.
Results
Of the 598 subjects (63–93 years) in the sample, 65.4% 
were women. Table 1 shows the sociodemographic char-
acteristics, lifestyle, health conditions, and BMD of the 
sample, stratified by sex. Men and women were predom-
inantly physically active older adults, without ADL de-
pendency, with no history of falls in the last year, and with 
hypovitaminosis D. Most women had 1–4 years of school-
ing, did not consume alcohol, and never smoked. Most 
men had 12 years or more of schooling, high alcohol con-
sumption, and were former smokers. The proportion of 
women and men with sarcopenia was 17.0% (95% CI: 
12.4–22.9) and 28.8% (95% CI: 21.3–37.7), respectively.
There was a predominance of women with osteopenia/
osteoporosis in total BMD (52.1%; 95% CI: 44.5–59.7), LS-
BMD (62.5%; 95% CI: 55.2–69.3), and FN-BMD (70.9%; 
95% CI: 64.5–76.6). For men, among the characteristics re-
lated to osteopenia/osteoporosis, altered FN-BMD (64.9%; 
95% CI: 54.4–74.2) was the most prevalent (Table 1).
The associated characteristics between BMD and sar-
copenia, for women and men, are presented in Table 2. 
For women, sarcopenia was positively associated with all 
altered BMD characteristics even after the adjustments in 
models 1, 2, and 3. In model 3 (final), women with sarco-
penia had, respectively, 11.08 (95% CI: 3.48–31.97), 12.25 
(95% CI: 3.66–40.96), and 5.59 (95% CI: 1.64–19.05) 
times to present osteopenia/osteoporosis in total BMD, 
LS-BMD, and FN-BMD. For men, data from the crude 
and adjusted analysis showed sarcopenia was associated 
with osteopenia/osteoporosis except according to total 
BMD. In the adjusted analysis, in model 3, men with sar-
copenia had 2.90 (95% CI: 1.30–6.48) and 7.95 (95% CI: 
3.23–19.57) higher chance of having osteopenia/osteopo-
rosis in LS-BMD and FN-BMD, respectively.
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Discussion
In this study, the proportion of altered osteopenia/os-
teoporosis was 52.1% for total BMD, 62.5% for LS-BMD, 
and 70.9% for FN-BMD in women, while for men, altered 
BMD proportion was 29.3% for total BMD, 24.5% for LS-
BMD, and 64.9% for FN-BMD. After adjustments, sarco-
penia was positively associated with altered BMD for LS-
BMD and FN-BMD characteristics in both sexes, and 
with total BMD only for women.
The results of this study showed a high proportion of 
osteopenia/osteoporosis, especially among women, as 
verified by other studies [29, 30]. In the study of Camargo 
et al. [29], the proportion of osteopenia of FN-BMD and 
osteoporosis was 57.4 and 12.8% in men, and 56.5 and 
22.2% in women from São Paulo, Brazil, respectively. 
Pereira et al. [14] diagnosed 33.8% of men in the Federal 
District, Brazil, with osteoporosis, and 47.5% with osteo-
penia, totaling 81.3% of the sample with abnormal BMD. 
Gonçalves et al. [30], in Portugal, identified a proportion 
of osteopenia and osteoporosis, respectively, of 50 and 
11% in women, and 32 and 2% in men. It is worth noting 
that separate samples were used.
A possible explanation for men to present a higher 
proportion of sarcopenia is their greater muscle mass, but 
also their greater loss of muscle mass with the advance-
ment of age [31]. The muscle loss is due to the decline of 
growth hormone, insulin-related growth factor 1, and 
testosterone [32].
The positive association between sarcopenia and al-
tered BMD is consistent with previous studies [4, 33]. 
Several potential mechanisms for sarcopenia, as well as 
the relation between sarcopenia and altered BMD, have 
been investigated to explain this association [6]. In the 
study of Bijlsma et al. [2], in both older men and women, 
sarcopenia (MMA/height2) was associated with BMD.
Muscles and bones present genetic, molecular [1], me-
chanical [1, 6], and functional [6] interactions. However, 
the area related to mechanical interaction is the most ac-
cepted and recognized [1]. The muscles are connected to 
the bones and it involves movements through an active 
contraction. By their direct physical connection, the mus-
cles expose the bone to a great variety of mechanical stim-
ulus [1]. For individuals with sarcopenia, this relation is 
modified, and it can be explained by the way sarcopenia 
can lead to a reduction of bone resistance, due to the re-
duction of the mechanical load to the skeleton [7]. The 
weaker muscles will produce less maximum force, due to 
decreased mechanical stimulation, which leads to re-
duced bone remodeling [34, 35]. Recent findings suggest 
that decreased muscle mass may deteriorate bone micro-
architecture [36]. The interest in muscle/bone relation-
ship, as well as muscle biology, has increased in recent 
years. Nevertheless, physiological and pathological mech-
anisms related to these tissues remain unclear [6].
The results also showed that sarcopenia was associated 
with altered total BMD only in women. Postmenopausal 
hormone changes, especially estrogen deficiency, are risk 
factors for osteoporosis [4, 37]. The decrease in estrogen 
levels affects the acceleration of reabsorption activity and 
increases bone turnover [38]. It leads to impairment and 
imbalance of bone activity, with a negative balance of cal-
cium especially in the mandible, maxilla, and long bones 
[39], which are the main bones evaluated in the total scan 
in bone densitometry.
A possible explanation for the association between sar-
copenia and BMD of the femoral neck and lumbar spine, 
and not for total body BMD in men, is that femoral neck 
and lumbar spine are considered the gold standard for the 
diagnosis of osteoporosis [40], these being the most eval-
uated regions, as well as the distal third of the radius due 
to the risk of fracture. This result may have occurred due 
to the calculation of density measurement, in addition to 
the fact that age-related bone loss differs according to the 
skeletal regions or specific areas assessed [41].
This study has limitations and strengths. One of the 
limitations refers to the cross-sectional design, which 
precludes inferences about the outcome. The losses of 
participation on the tests may lead to selection bias. The 
participants who attended had better health conditions 
than those who refused, which may lead to underestima-
tion of the proportion of sarcopenia and altered BMD, 
underestimating the found associations. Another limita-
tion includes the lack of indicators of muscular strength 
and motor performance for the definition of sarcopenia, 
which were not available for analysis. Also, other impor-
tant minerals for bone and muscle health, such as phos-
phate, calcium, iron, magnesium, potassium, as well as 
interleukin 6, parathyroid hormone, growth hormone 
[5], and tumor necrosis factor-alpha were not evaluated.
The main strengths of the study include the evaluation 
of body composition, bone densitometry, and laboratory 
tests using standardized procedures, as well as the appli-
cation of questionnaires with validated scales. Also, this 
study has one of the largest samples of older adults in a 
population-based survey conducted in Brazil to investi-
gate sarcopenia using the gold standard established in the 
literature, which is difficult to see in population studies.
The results of this study reinforce the importance of 
studying sarcopenia and osteopenia/osteoporosis in the 
Osteopenia/Osteoporosis and Its 
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older population, due to its clinical and health implica-
tions, and may be used to support the clinical practice of 
health professionals in different areas, as well as contrib-
uting to health actions.
Final Considerations
The proportion of osteopenia/osteoporosis differed 
between the sexes, with higher values for women, consid-
ering the three measurements. For men, only the FN-
BMD had a high proportion of osteopenia/osteoporosis. 
Sarcopenia was positively associated with osteopenia/os-
teoporosis, in both sexes, except for total BMD in men.
The combination of sarcopenia and osteopenia/osteo-
porosis can have a social and economic impact, due to its 
complications in the health of the affected population. 
The results show the importance of studying these char-
acteristics in the older population. It can collaborate with 
the implementation of health actions capable of prevent-
ing, stimulating early diagnosis of the population at risk, 
treating, and even rehabilitating them.
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